Orjon Rroj | Neuroscience | Best Researcher Award- 12050

Posted on by ScienceFather

Dr. Orjon Rroj | Neuroscience | Best Researcher Award

Lecturer and researcher at European University of Tirana in Albania

Dr. Orjon Rroji is a distinguished lecturer and researcher in neuroscience based in Shkodër, Albania. Currently, he serves as a lecturer at the European University of Tirana, teaching subjects such as Histology, Medical Biochemistry, and Cognitive Psychology. He completed his PhD in Kinesiology at KU Leuven, Belgium, focusing on neuroplasticity and brain stimulation techniques. His postdoctoral research at Burke Neurological Institute, USA, investigated stroke recovery. Dr. Rroji has actively participated in Erasmus+ teaching mobilities across Europe and contributed significantly to projects like AI-4-NICU and Laserlab Europe. He is also an award recipient for his innovative work in non-invasive brain stimulation. 📚🧠✨

Publication Profile

Google Scholar

Education

Dr. Orjon Rroji has an extensive academic background in neuroscience and biology. He completed his postdoctoral fellowship at Burke Neurological Institute, affiliated with Weill Cornell Medicine, New York, focusing on stroke recovery through the NeuroCures NY project. He earned his PhD in Kinesiology from KU Leuven, Belgium, with research on enhancing neuroplasticity using brain stimulation techniques. His Master’s degree in Biology of Behaviour was obtained from the University of Florence, Italy, where he studied genetic variations in Alzheimer’s disease. Dr. Rroji also holds a Bachelor’s in General Biology from the University of Padua, Italy, focusing on the effects of olfactory mucosa lesions in mice. 🧠🎓🔬

Work Experience

Dr. Orjon Rroji is a dedicated academic professional currently serving as a Lecturer at the European University of Tirana (UET), Albania, where he teaches Histology, Medical Biochemistry, Cognitive Psychology, and Research Methods for Healthcare. He has participated in Erasmus+ Teaching Mobilities across Romania, Lithuania, and Poland. Dr. Rroji previously held roles at Burke Neurological Institute, USA, contributing to stroke recovery research and teaching neuroscience. He has also lectured at Hunter College, CUNY, and various Albanian universities, focusing on medical and clinical biochemistry, neurology, and human biology. He has a strong background in curriculum development, supervising theses, and international academic collaboration. 🌍🧠📚

Research Focus

Dr. Orjon Rroji’s research focuses primarily on neuroscience 🧠, with a specialization in neuroplasticity and brain stimulation techniques. His work explores the mechanisms of motor learning, memory consolidation, and stroke recovery, often employing non-invasive brain stimulation like transcranial direct current stimulation (tDCS) to enhance neuroplasticity. Dr. Rroji has also delved into epigenetic regulation in neurological diseases, investigating potential therapeutic targets for conditions like ferroptosis in neurons. His interdisciplinary studies combine elements of biomedical sciences, cognitive neuroscience, and biochemistry, aiming to uncover novel treatment strategies for neurodegenerative disorders and improving rehabilitation outcomes. 📚🔬💡

Conclusion

Dr. Orjon Rroji demonstrates notable strengths in stroke recovery research with direct implications for community health, making him a strong candidate for the Research for Community Impact Award. His innovative work and award-winning projects also position him competitively for the Best Researcher Award. Continued expansion in publications and community-based collaborations could further reinforce his candidacy in both categories.

Publication Top Notes 

  • Anodal tDCS Over the Primary Motor Cortex Facilitates Long-Term Memory Formation Reflecting Use-Dependent Plasticity
    • Authors: O. Rroji, K. van Kuyck, B. Nuttin, N. Wenderoth
    • Journal: PLoS One, 2015, Volume 10, Issue 5, Article e0127270
    • Citations: 82
  • Epigenetic Regulators of Neuronal Ferroptosis Identify Novel Therapeutics for Neurological Diseases: HDACs, Transglutaminases, and HIF Prolyl Hydroxylases
    • Authors: O. Rroji, A. Kumar, S.S. Karuppagounder, R.R. Ratan
    • Journal: Neurobiology of Disease, 2021, Volume 147, Article 105145
    • Citations: 27
  • Factors Influencing Brain Recovery from Stroke via Possible Epigenetic Changes
    • Authors: O. Rroji, C. Mucignat
    • Year: 2024
  • Improving Neuroplasticity and Motor Learning by Brain Stimulation Techniques
    • Authors: O. Rroji, N. Wenderoth, B. Nuttin, K. van Kuyck
    • Institution: KU Leuven, 2016
  • Interhemispheric Transfer of Motor Skill Tested in a Rat Model
    • Authors: O. Rroji, D. Leenus, K. van Kuyck, B. Nuttin, N. Hellings, R. Meesen, et al.
    • Conference: Society for Neuroscience (SFN) Annual Meeting, 2012, New Orleans, USA

 

 

Mahmoud A. Abdelkawy | Chemistry | Best Researcher Award -12049

Posted on by ScienceFather

Dr. Mahmoud A. Abdelkawy |Chemistry | Best Researcher Award

Lecturer at Chemistry Department, Faculty of Science Tanta University in Egypt

Dr. Mahmoud A. Abdelkawy is a dedicated civil engineer and academic with a focus on structural resilience and sustainable construction. With extensive experience in both teaching and consulting, Dr. Abdelkawy contributes valuable insights into the field of structural engineering, particularly in seismic safety. His work has had a lasting impact on the development of earthquake-resistant infrastructure and sustainable building practices in Egypt and the MENA region.

Publication Profile

Google Scholar

scopus.com

Qualifications and Education

  • Dr. Mahmoud A. Abdelkawy earned his PhD in Civil Engineering from Cairo University, with a specialization in Structural Engineering. He also holds a Master’s degree in Civil Engineering from the same institution, where his thesis focused on seismic design and analysis. His undergraduate studies were completed at Alexandria University, where he earned a Bachelor’s degree in Civil Engineering with high honors.

Professional Experience

  • Dr. Abdelkawy is an Associate Professor of Structural Engineering at Cairo University. He has over 15 years of experience in academia and industry, working on projects related to seismic retrofitting, structural analysis, and sustainable construction materials. He has collaborated with various engineering firms on infrastructure projects across the Middle East and North Africa, providing expertise in earthquake-resistant design. Dr. Abdelkawy is also a consultant for the Egyptian Ministry of Housing, where he advises on structural safety and resilience for urban development projects.

Research Focus

Dr. Abdelkawy’s research centers on seismic resilience, structural analysis, and sustainable construction. He is particularly interested in developing methods for retrofitting buildings in earthquake-prone areas and enhancing structural durability using eco-friendly materials. His recent projects focus on assessing the seismic vulnerability of historical structures and exploring the use of advanced composites for improving building performance under extreme conditions. Through his research, Dr. Abdelkawy aims to improve construction safety and promote sustainable engineering practices in Egypt and beyond.

Conclusion

  • Given his expertise, commitment to research in chemistry, and the potential community impact of his work, Dr. Mahmoud Abdelkawy is a strong candidate for the Research and Community Impact Award. His work aligns well with the goals of this award, particularly if he continues to expand his research outputs and collaborative efforts.

Publication Top Notes 

  • Book Chapter: Biodegradable Materials-Based Sensors
    • Authors: Abdelkawy, M.A., El-Sherif, D.M., Ali, G.A.M.
    • Book: Handbook of Nanosensors: Materials and Technological Applications, 2024, Pages 347–380
    • Citations: 0
  • Thermal and Morphological Characterization of Biowaste Date Palm Fiber-Reinforced Polybenzoxazine and Epoxy Composites
    • Authors: Abdelkawy, M.A., Itsuno, S., El-Badawi, M.A., Aly, E.-S.A.
    • Journal: Polymer Composites, 2023, Volume 44, Issue 10, Pages 6393–6402
    • Citations: 6
  • Chiral Polyureas Derived from Cinchona Alkaloids: Highly Efficient Bifunctional Organocatalysts for the Asymmetric Michael Addition Reaction
    • Authors: Abdelkawy, M.A., Davin, C., Aly, E.-S.A., El-Badawi, M.A., Itsuno, S.
    • Journal: ChemistrySelect, 2021, Volume 6, Issue 43, Pages 11971–11979
    • Description: This research highlights the development of chiral polyureas derived from cinchona alkaloids as efficient catalysts for asymmetric Michael addition reactions, showing potential for sustainable and efficient synthesis in organic chemistry.
    • Citations: 1
  • Chitosan-Supported Cinchona Urea: Sustainable Organocatalyst for Asymmetric Michael Reaction
    • Authors: Abdelkawy, M.A., Aly, E.-S.A., El-Badawi, M.A., Itsuno, S.
    • Journal: Catalysis Communications, 2020, Volume 146, Article 106132
    • Citations: 11
  • Synthesis of Cinchona Urea Polymers and Their Evaluation as Catalysts in Asymmetric Reactions
    • Authors: Abdelkawy, M.A., Aly, E.-S.A., El-Badawi, M.A., Itsuno, S.
    • Journal: ChemistrySelect, 2020, Volume 5, Issue 21, Pages 6294–6298
    • Citations: 4

 

 

Hong-gang Lou | Pharmacology | Best Researcher Award

Posted on by ScienceFather

Dr. Hong-gang Lou | Pharmacology | Best Researcher Award

Dr at the Second Affiliated Hospital, Zhejiang University School of Medicine,  China

Hong-gang Lou is a distinguished pharmacologist and clinical pharmacology expert serving as the Deputy Director of the Clinical Pharmacology Center and Director of the Pharmaceutical Bioanalysis Laboratory at The Second Affiliated Hospital Zhejiang University School of Medicine. He has significantly contributed to the field of pharmacology through leadership roles in various professional societies and committees.

Publication Profile

Scopus

🎓 Education

Hong-gang Lou completed his medical education at Zhejiang University, where he gained in-depth knowledge in pharmacology and medicine. He pursued advanced studies and training that equipped him with expertise in clinical pharmacology, pharmaceutical bioanalysis, and toxicology. His educational background forms the foundation for his influential career in medical research and clinical practice.

💼 Experience

Since August 1992, Hong-gang Lou has held multiple key positions at The Second Affiliated Hospital Zhejiang University School of Medicine, including Deputy Director of Clinical Pharmacology and Director of the Pharmaceutical Bioanalysis Laboratory. He also serves as the Chairperson of the Pharmacological Toxicology Society of Zhejiang Toxicology Society and has played vital roles in various medical associations, enhancing clinical trials and ethical standards in the region.

🏆 Awards and Honors

Throughout his career, Hong-gang Lou has received several awards recognizing his contributions to pharmacology and clinical research. His dedication to improving clinical practices and ensuring drug safety has earned him respect and accolades from peers in the medical community. He has also been acknowledged for his role in advancing ethical standards in clinical trials.

🔍 Research Focus

Hong-gang Lou’s research focuses on clinical pharmacology, pharmaceutical bioanalysis, and toxicology. He investigates drug metabolism, pharmacokinetics, and the ethical implications of clinical trials, aiming to enhance drug safety and efficacy. His work significantly contributes to the understanding of pharmacological therapies, ultimately improving patient care and therapeutic outcomes.

Conclusion

Hong-gang Lou is a highly qualified candidate for the Best Researcher Award, characterized by his extensive experience, leadership in pharmacology, and commitment to ethical standards in clinical trials. His strong educational background and impactful research contributions position him as a leader in the field. By focusing on improving publication output, fostering interdisciplinary collaborations, and enhancing public outreach, Lou can further amplify his contributions to pharmacology and patient care. With these enhancements, he is well-equipped to make lasting impacts in the field and deserves recognition as an outstanding researcher.

Publication Top Notes  

  1. Population Pharmacokinetic Analysis of Febuxostat with High Focus on Absorption Kinetics and Food Effect
    • Chen, W., Jiang, B., Ruan, Z., Hu, Y., Lou, H. (2024)
    • BMC Pharmacology and Toxicology, 25(1), 57.

 

  1. Pharmacokinetics of PD-1/PD-L1 Monoclonal Antibodies from Cynomolgus Monkey to Human: Comparison of Different Approaches
    • Chen, W., Wang, L., Ruan, Z., Lou, H., Jiang, B. (2024)
    • Journal of Pharmaceutical Sciences, 113(9), pp. 2915–2921.

 

  1. Physiologically Based Absorption Modeling to Predict the Bioequivalence of Two Apixaban Formulations
    • Luo, T., Wang, L., Ruan, Z., Zhao, P., Jiang, B. (2024)
    • Clinical and Translational Science, 17(5), e13819.

 

  1. Bioequivalence Study of Epalrestat for Healthy Chinese Subjects
    • Yang, D., Wang, X., Duan, Y., Lou, H., Chen, J. (2024)
    • Clinical Pharmacology in Drug Development, 13(5), pp. 485–490.

 

  1. Pharmacokinetics, Pharmacodynamics, and Safety of Frunexian in Healthy Chinese Volunteer Adults: A Randomized Dose-Escalation Phase I Study
    • Zhang, J.-Y., Ruan, Z.-R., Jiang, B., Wang, L.-L., Lou, H.-G. (2024)
    • Clinical and Translational Science, 17(4), e13787.

 

  1. Phase I Clinical Trial Evaluating the Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of HSK21542 Injection in Healthy Volunteers
    • Shao, R., Wang, H.-Y., Ruan, Z.-R., Yan, M., Lou, H. (2024)
    • Basic and Clinical Pharmacology and Toxicology.

 

  1. In Silico Prediction of Bioequivalence of Atorvastatin Tablets Based on GastroPlus™ Software
    • Wang, L., Chen, J., Chen, W., Yang, D., Jiang, B. (2023)
    • BMC Pharmacology and Toxicology, 24(1), 69.

 

  1. Physiologically Based Absorption Modeling to Predict the Bioequivalence of Two Cilostazol Formulations
    • Wang, L., Zhao, P., Luo, T., Ruan, Z., Jiang, B. (2023)
    • Clinical and Translational Science, 16(11), pp. 2323–2330.